| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8952432 | Ophthalmology | 2018 | 8 Pages |
Abstract
Early PPV as a strategy for treatment of PDR without macular edema demonstrates cost-utility similar to management with PRP and more favorable cost-utility compared with IVR in the short term. This advantage over IVR continues when lifetime costs are factored.
Keywords
RVUintravitreal ranibizumabPDRIVRpars plana vitrectomyQALYPrPPPVDRSDMECPTpanretinal photocoagulationDiabetic macular edemaCurrent Procedural TerminologyProliferative diabetic retinopathyQuality-adjusted life yearsVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)relative value unit
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
James MD, Jonathan S. MD, Nicolas A. MD, William E. MD,